Viewing Study NCT04372433


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2025-12-31 @ 12:23 PM
Study NCT ID: NCT04372433
Status: COMPLETED
Last Update Posted: 2025-02-14
First Post: 2020-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
Sponsor: Immune-Onc Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module